NCT00419484已完成不适用
Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,000
- 试验地点
- 1
研究概览
简要总结
We want to investigate the effects of pioglitazone on cardiovascular events in Japanese patients with type 2 diabetes.
详细描述
Primary composite endpoints:
Cardiovascular death Non-fatal myocardial infarction and angina Non-fatal stroke Renal failure (hemodialysis/doubling of serum creatinine)
Secondary endpoints:
urinary albumin excretion diabetic retinopathy hyperlipidemia hypertension gout
研究设计
- 研究类型
- Observational
- 观察模型
- Defined Population
- 时间视角
- Prospective
入排标准
- 年龄范围
- 20 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •type 2 diabetes HbA1c: more than 7% and less than 9%
排除标准
- •insulin treatment
研究者
研究点 (1)
Loading locations...
相似试验
招募中
4 期
Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus ParticipantsType 2 Diabetes Mellitus in ObeseHeart Failure With Preserved Ejection FractionNCT05838287The University of Texas Health Science Center at San Antonio78
已完成
4 期
Effect of pioglitazone on cardiovascular events in high-risk diabetic patients with acute brain infarctioAcute brain infarction with type2 diabetes mellitus.JPRN-UMIN000001112Kyushu University600
终止
4 期
Pioglitazone Protects Diabetes Mellitus (DM) Patients Against Re-Infarction (PPAR Study)Myocardial InfarctionDiabetes MellitusNCT00212004National Cerebral and Cardiovascular Center, Japan630
已完成
2 期
Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.Diabetes MellitusNCT00770640Takeda40
已完成
2 期
Effects of pioglitazone on coronary atherosclerotic plaques of patients with impaired glucose tolerance or type 2 diabetes mellitus:a randomized,open rabelled,prospective study.Impaired glucose tolerance or type 2 diabetes mellitus with coronary artery diseaseJPRN-C000000230Chiba University Graduate School of Medicine40